MuseCell Innovations PTE Ltd is a Singapore-based intellectual property licensing company established in 2024 that acts as the sole global licensor of Professor Mari Dezawa's foundational MUSE cell technology. Originally discovered in 2010 at Tohoku University, MUSE cells (Multilineage-differentiating Stress Enduring cells) are naturally occurring, pluripotent-like, immune-privileged stem cells capable of targeted tissue repair without the risk of forming tumors. As an IP holding entity, MuseCell Innovations does not treat patients directly, but instead licenses its proprietary extraction, isolation, and culture methodologies—known as the Dezawa Method™—to authorized global manufacturers and clinical providers.